Li Zhang

9PUBLICATIONS
37CO-AUTHORS
Immunogenetics (incl. genetic immunology)Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 27, 2025
Navigating the Prognostic Complexity of IgH Cytogenetic Abnormalities in Multiple Myeloma Among Diverse IgH Cytogenetic Abnormalities-Involved High-Risk Stratifications.

Yanqiu Xiong, Meng Li, Yan Li

|May 18, 2025
A comprehensive analysis of bone marrow-derived cytogenetic abnormalities in multiple myeloma patients with extramedullary disease.

Juan Xu, Haonan Yang, Jingcao Huang

|Feb 18, 2025
Evaluation of anti-CD38 monoclonal antibody-based immunotherapy in multiple myeloma with renal insufficiency: a systematic review and meta-analysis.

Hexiang Bai, Chunlan Zhang, Ailin Zhao

|Sep 05, 2024
A predictive risk-scoring model for survival prognosis of multiple myeloma based on gain/amplification of 1q21: Experience in a tertiary hospital in South-Western China.

Yanqiu Xiong, Shanshan Liang, Wenjiao Tang

|Aug 06, 2024
Maintenance therapy for cytogenetically high-risk multiple myeloma: landscape in the era of novel drugs.

Xinyuan Gu, Wenjiao Tang, Li Zhang

|Jul 20, 2024
Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma.

Wenjiao Tang, Yan Li, Li Zhang

Pageof 2

Frequent Collaborators

4 joint publications

Yuhuan Zheng

3 joint publications

Wenjiao Tang

1 joint publications

Tingyu Wang

1 joint publications

Xiuhua Sun